| Endometrial Undifferentiated Carcinoma studied in …STUDIED_INderived17 of 17show fewer |
|---|
| → studied in | NCT05256225Phase 3 · recruiting Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (5 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05112601Phase 2 · recruiting Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (5 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03660826Phase 2 · active not recruiting Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone · condition mapped ONTOLOGY_EXACT · 17 trials mapped (5 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03914612Phase 3 · active not recruiting Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 17 trials mapped (5 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03120624Phase 1 · active not recruiting VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 17 trials mapped (5 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04719273Phase 2 · completed Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer · condition mapped CURATED_BROADER · 17 trials mapped (5 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02020707Phase 1 · completed Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers · condition mapped ONTOLOGY_EXACT · 17 trials mapped (5 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05390021NA · withdrawn PET/MRI in Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 17 trials mapped (5 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00492778Phase 2 · unknown Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 17 trials mapped (5 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02728258Phase 2 · completed Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 17 trials mapped (5 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02065687Phase 2/Phase 3 · unknown Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 17 trials mapped (5 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01935973Phase 1 · completed Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 17 trials mapped (5 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01440998Phase 1 · completed Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 17 trials mapped (5 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01642082Phase 2 · completed Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 17 trials mapped (5 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00888173Phase 2 · completed Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 17 trials mapped (5 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01225887Phase 2 · completed Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 17 trials mapped (5 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00575952Phase 1 · completed Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 17 trials mapped (5 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |